Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trial

International Journal of Cardiology

Volumn 203, Issue , 2016, Pages 647-652

  Roblek, Tina ^a,b   Deticek, Andreja ^a   Leskovar, Bostjan ^c   Suskovic, Stanislav ^a   Horvat, Matej ^b   Belic, Ales ^b   Mrhar, Ales ^a   Lainscak, Mitja ^a,d  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Lek dd   (Slovenia)

^c Dialysis Department   (Slovenia)

^d General Hospital Celje   (Slovenia)

Author keywords

Clinical relevance; Drug drug interactions; Heart failure; Intervention; Pharmacist

Indexed keywords

ALDOSTERONE ANTAGONIST; ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; CARDIOVASCULAR AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HEART ARRHYTHMIA; HEART FAILURE; HOSPITAL READMISSION; HUMAN; HYPERKALEMIA; HYPOVOLEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHARMACIST; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; DRUG INTERACTION; HOSPITAL DISCHARGE; HOSPITAL PHARMACY; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HEART FAILURE; HUMANS; MALE; PATIENT DISCHARGE; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84952673552     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.10.206     Document Type: Article

References (33)

1. C.D. Venturini, P. Engroff, L.S. Ely, Z. LF de A, G. Schroeter, I. Gomes, and et al. Gender differences, polypharmacy, and potential pharmacological interactions in the elderly Clinics (Sao Paulo) 66 2011 1867 1872
2. S. Dechanont, S. Maphanta, B. Butthum, and C. Kongkaew Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis Pharmacoepidemiol Drug Saf 23 2014 489 497
3. C.S. Moura, F.A. Acurcio, and N.O. Belo Drug-drug interactions associated with length of stay and cost of hospitalization J. Pharm. Pharm. Sci. 12 2009 266 272
4. P. Vonbach, A. Dubied, S. Krähenbühl, and J.H. Beer Evaluation of frequently used drug interaction screening programs Pharm World Sci 30 2008 367 374
5. A.B. Taegtmeyer, G.A. Kullak-Ublick, N. Widmer, V. Falk, and A. Jetter Clinical usefulness of electronic drug-drug interaction checking in the care of cardiovascular surgery inpatients Cardiology 123 2012 219 222
6. Y.-F. Chen, A.J. Avery, K.E. Neil, C. Johnson, M.E. Dewey, and I.H. Stockley Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice Drug Saf 28 2005 67 80
7. S.K. Milfred-LaForest, S.L. Chow, R.J. DiDomenico, K. Dracup, C.R. Ensor, W. Gattis-Stough, and et al. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network Pharmacotherapy 33 2013 529 548
8. P.J. McDonnell, and M.R. Jacobs Hospital admissions resulting from preventable adverse drug reactions Ann Pharmacother 36 2002 1331 1336
9. S.L. Kane, R.J. Weber, and J.F. Dasta The impact of critical care pharmacists on enhancing patient outcomes Intensive Care Med 29 2003 691 698
10. L.L. Leape, D.J. Cullen, M.D. Clapp, E. Burdick, H.J. Demonaco, J.I. Erickson, and et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit JAMA 282 1999 267 270
11. C.A. Bond, and C.L. Raehl Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals Pharmacotherapy 26 2006 735 747
12. R. Lowrie, F.S. Mair, N. Greenlaw, P. Forsyth, P.S. Jhund, A. McConnachie, and et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction Eur Heart J 33 2012 314 324
13. S.L. Koshman Pharmacist care of patients with heart failure; a systematic review of randomized trials Intern Med 168 2008 687
14. A. Barker, P. Barlis, D. Berlowitz, K. Page, B. Jackson, and W.K. Lim Pharmacist directed home medication reviews in patients with chronic heart failure: a randomised clinical trial Int J Cardiol 159 2012 139 143
15. T. Roblek, K. Trobec, A. Mrhar, and M. Lainscak Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease Arch. Med. Sci. 5 2014 920 932
16. M. Lainscak, L.M. Hodoscek, H.-D. Düngen, M. Rauchhaus, W. Doehner, S.D. Anker, and et al. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure Wien Klin Wochenschr 121 2009 309 313
17. M. Lainščak, J.G.F. Cleland, M.J. Lenzen, F. Follath, M. Komajda, and K. Swedberg International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey Eur J Heart Fail 9 2007 292 299
18. I. Sarc, T. Jeric, K. Ziherl, S. Suskovic, M. Kosnik, S.D. Anker, and et al. Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease J Eval Clin Pract 17 2011 737 743
19. S. Dumbreck, A. Flynn, M. Nairn, M. Wilson, S. Treweek, S.W. Mercer, and et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines BMJ 350 2015 h949-h949
20. S.M. Udani, and J.L. Koyner The effects of heart failure on renal function Cardiol Clin 28 2010 453 465
21. U.V. Mateti, T. Rajakannan, H. Nekkanti, V. Rajesh, S.R. Mallaysamy, and P. Ramachandran Drug-drug interactions in hospitalized cardiac patients J Young Pharm 3 2011 329 333
22. N. Radosević, M. Gantumur, and V. Vlahović-Palcevski Potentially inappropriate prescribing to hospitalised patients Pharmacoepidemiol Drug Saf 17 2008 733 737
23. B. Straubhaar, S. Krähenbühl, and R.G. Schlienger The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge Drug Saf. 29 2006 79 90
24. B.F. Palmer Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system N Engl J Med 351 2004 585 592
25. J.M. Testani, S.E. Kimmel, D.L. Dries, and S.G. Coca Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction Circ Heart Fail 4 2011 685 691
26. M.J. Armahizer, S.L. Kane-Gill, P.L. Smithburger, A.M. Anthes, and A.L. Seybert Comparing drug-drug interaction severity ratings between bedside clinicians and proprietary databases ISRN Crit. Care. 2013 2013 1 6
27. S. Marusic, V. Bacic-Vrca, P.R. Obreli Neto, M. Franic, V. Erdeljic, and N. Gojo-Tomic Actual drug-drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study Eur J Clin Pharmacol 69 2013 1717 1724
28. P.L. Smithburger, S.L. Kane-Gill, N.J. Benedict, B.A. Falcione, and A.L. Seybert Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings Ann Pharmacother 44 2010 1718 1724
29. P.A. Glassman, B. Simon, P. Belperio, and A. Lanto Improving recognition of drug interactions: benefits and barriers to using automated drug alerts Med Care 40 2002 1161 1171
30. M.-L. Yeh, Y.-J. Chang, P.-Y. Wang, Y.-C.J. Li, and C.-Y. Hsu Physicians' responses to computerized drug-drug interaction alerts for outpatients Comput Methods Programs Biomed 111 2013 17 25
31. P.J. Kaboli, A.B. Hoth, B.J. McClimon, and J.L. Schnipper Clinical pharmacists and inpatient medical care: a systematic review Arch Intern Med 166 2006 955 964
32. M.L. Becker, M. Kallewaard, P.W. Caspers, L.E. Visser, H.G. Leufkens, and B.H. Stricker Hospitalisations and emergency department visits due to drug-drug interactions: a literature review Pharmacoepidemiol Drug Saf 16 2007 641 651
33. G. Hesselink, M. Zegers, M. Vernooij-Dassen, P. Barach, C. Kalkman, M. Flink, and et al. Improving patient discharge and reducing hospital readmissions by using Intervention Mapping BMC Health Serv Res 14 2014 389